BibTex RIS Kaynak Göster

F-18-FDG PET/CT FINDINGS IN DIFFERENTIATED PAPILLARY CARCINOMA OF THYROID AND DETERMINATION OF METABOLIC ACTIVITY

Yıl 2017, Cilt: 4 Sayı: 3, 47 - 50, 01.10.2017

Mehmet Oğulcan Tezel Oğuz Mercan Öznur Yumurtacı Cansu Kurt Gülay Durmuş Altun

Öz

Aims: In well differentiated thyroid cancers, FDG PET has a relatively low sensitivity. F-18 FDG PET/CT is an imaging method which is used before the treatment and in high risk patient groups with suspected recurrent disease. In this study we aim to determine the character of metabolic activity in differentiated thyroid cancer and in case of metastasis and to evaluate the findings of F-18-FDG PET/CT images in high risk patient group of differentiated thyroid cancer. Methods: The data of 79 patients who underwent imaging for staging or restaging and followed at Trakya Univerısity Faculty of Medicine from 2010 to 2015, were included in this study. Patient reports were analyzed retrospectively. Age, gender, size of thyroid lesion, presence of lymphadenopathy, other organ metastases (lung, liver, brain, bone) were included in the study. Results: The findings of 79 patients (29 male, 50 female) with papillary differentiated thyroid cancer were included in the analyses. The mean age of participants was 51±15 years. 14 patients (18%) were evaluated as normally. Recurırent disease was detected in the thyroid gland of 10 patients (13%) (SUVmax: 6.2±5.1; 2.3-19.3). In 54 patients (68%) lymph node metastasis was detected (SUVmax; 5.8±5.1; 2.1-24.2). 12 patients had liver metastasis (SUVmax: 5.7±3.9; 2.0-11.7), 12 patients had bone metastasis (SUVmax: 6.1±2.9; 2.2-13.9), 8 patients had lung metastasis (SUVmax: 4.3±4.5; 1.0-4.9) and one patient had brain metastasis (SUVmax: 10.2). Conclusion: Papillary differentiated thyroid cancer is associated with a tumor showing low glucose affinity, but it is understood that the tumor changes its behavior and gets metabolically active in the patients within the high risk group and in those with systemic metastasis

Anahtar Kelimeler

Thyroid cancer F-18 FDG PET/CT

Yıl 2017, Cilt: 4 Sayı: 3, 47 - 50, 01.10.2017

Mehmet Oğulcan Tezel Oğuz Mercan Öznur Yumurtacı Cansu Kurt Gülay Durmuş Altun

Öz

Toplam 0 adet kaynakça vardır.

Ayrıntılar

Diğer ID JA43VY84VB
Bölüm Araştırma Makalesi
Yazarlar

Mehmet Oğulcan Tezel Bu kişi benim

Oğuz Mercan Bu kişi benim

Öznur Yumurtacı Bu kişi benim

Cansu Kurt Bu kişi benim

Gülay Durmuş Altun Bu kişi benim

Yayımlanma Tarihi 1 Ekim 2017
Gönderilme Tarihi 1 Ekim 2017
Yayımlandığı Sayı Yıl 2017 Cilt: 4 Sayı: 3

Kaynak Göster

APA Tezel, M. O., Mercan, O., Yumurtacı, Ö., Kurt, C., vd. (2017). F-18-FDG PET/CT FINDINGS IN DIFFERENTIATED PAPILLARY CARCINOMA OF THYROID AND DETERMINATION OF METABOLIC ACTIVITY. Turkish Medical Student Journal, 4(3), 47-50.
AMA Tezel MO, Mercan O, Yumurtacı Ö, Kurt C, Altun GD. F-18-FDG PET/CT FINDINGS IN DIFFERENTIATED PAPILLARY CARCINOMA OF THYROID AND DETERMINATION OF METABOLIC ACTIVITY. TMSJ. Ekim 2017;4(3):47-50.
Chicago Tezel, Mehmet Oğulcan, Oğuz Mercan, Öznur Yumurtacı, Cansu Kurt, ve Gülay Durmuş Altun. “F-18-FDG PET/CT FINDINGS IN DIFFERENTIATED PAPILLARY CARCINOMA OF THYROID AND DETERMINATION OF METABOLIC ACTIVITY”. Turkish Medical Student Journal 4, sy. 3 (Ekim 2017): 47-50.
EndNote Tezel MO, Mercan O, Yumurtacı Ö, Kurt C, Altun GD (01 Ekim 2017) F-18-FDG PET/CT FINDINGS IN DIFFERENTIATED PAPILLARY CARCINOMA OF THYROID AND DETERMINATION OF METABOLIC ACTIVITY. Turkish Medical Student Journal 4 3 47–50.
IEEE M. O. Tezel, O. Mercan, Ö. Yumurtacı, C. Kurt, ve G. D. Altun, “F-18-FDG PET/CT FINDINGS IN DIFFERENTIATED PAPILLARY CARCINOMA OF THYROID AND DETERMINATION OF METABOLIC ACTIVITY”, TMSJ, c. 4, sy. 3, ss. 47–50, 2017.
ISNAD Tezel, Mehmet Oğulcan vd. “F-18-FDG PET/CT FINDINGS IN DIFFERENTIATED PAPILLARY CARCINOMA OF THYROID AND DETERMINATION OF METABOLIC ACTIVITY”. Turkish Medical Student Journal 4/3 (Ekim 2017), 47-50.
JAMA Tezel MO, Mercan O, Yumurtacı Ö, Kurt C, Altun GD. F-18-FDG PET/CT FINDINGS IN DIFFERENTIATED PAPILLARY CARCINOMA OF THYROID AND DETERMINATION OF METABOLIC ACTIVITY. TMSJ. 2017;4:47–50.
MLA Tezel, Mehmet Oğulcan vd. “F-18-FDG PET/CT FINDINGS IN DIFFERENTIATED PAPILLARY CARCINOMA OF THYROID AND DETERMINATION OF METABOLIC ACTIVITY”. Turkish Medical Student Journal, c. 4, sy. 3, 2017, ss. 47-50.
Vancouver Tezel MO, Mercan O, Yumurtacı Ö, Kurt C, Altun GD. F-18-FDG PET/CT FINDINGS IN DIFFERENTIATED PAPILLARY CARCINOMA OF THYROID AND DETERMINATION OF METABOLIC ACTIVITY. TMSJ. 2017;4(3):47-50.